2
Announcements
Trials
Browse
Landscape
Phase
Phase NA
2
Status
Recruiting
1
Active not recruiting
1
Sponsor Class
OTHER
1
INDUSTRY
1
Study Type
Interventional
2
Sponsor
Cancer Type
Gynecologic
2
Other neoplasm
1
Conditions
Endometrial Neoplasms
2
Uterine Prolapse
1
Uterine Cervical Neoplasms
1
Precancerous Conditions
1
Ovarian Neoplasms
1
Menstruation Disturbances
1
Leiomyoma
1
Endometriosis
1
Adenomyosis
1
Interventions
Specimen Handling
288
Magnetic Resonance Spectroscopy
238
pembrolizumab
228
Carboplatin
187
Cisplatin
153
Biopsy
151
Cyclophosphamide
144
Paclitaxel
133
Nivolumab
123
Gemcitabine
113
Bevacizumab
106
Radiotherapy
96
Dexamethasone
86
Pemetrexed
83
fludarabine
78
Fluorouracil
76
Doxorubicin
76
Docetaxel
76
atezolizumab
73
Radiation
72
Leucovorin
70
Rituximab
68
Oxaliplatin
66
venetoclax
61
durvalumab
61
Prednisone
61
Vincristine
56
Cetuximab
56
Lenalidomide
55
Etoposide
54
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Hysterectomy
×
30 days
×
Clear all
NCT07622901
2026-06-03
FIT-ENDO
University of Miami
Phase NA
Recruiting
42 enrolled
NCT07120945
2026-06-02
Embrace Gyn
Medtronic - MITG
Phase NA
Active not recruiting
70 enrolled